Deutsche Bank’s Biostage, Inc. Common Stock BSTG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-7
| Closed | – | – | 5335 |
|
|
2017
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 5272 |
|
|
2017
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 5289 |
|
|
2017
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 5262 |
|
|
2016
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 5209 |
|
|
2016
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 5420 |
|
|
2016
Q2 | $0 | Buy |
+7
| New | +$11 | ﹤0.01% | 5475 |
|
|
2015
Q4 | – | Sell |
-516
| Closed | – | – | 5507 |
|
|
2015
Q3 | $0 | Sell |
516
-35,101
| -99% | -$39.8K | ﹤0.01% | 5474 |
|
|
2015
Q2 | $50K | Buy |
35,617
+35,001
| +5,682% | +$85.7K | ﹤0.01% | 4600 |
|
|
2015
Q1 | $2K | Sell |
616
-5,000
| -89% | -$17K | ﹤0.01% | 5005 |
|
|
2014
Q4 | $17K | Buy |
5,616
+5,000
| +812% | +$24.8K | ﹤0.01% | 5566 |
|
|
2014
Q3 | $4K | Sell |
616
-32,105
| -98% | -$263K | ﹤0.01% | 5587 |
|
|
2014
Q2 | $341K | Buy |
32,721
+30,048
| +1,124% | +$256K | ﹤0.01% | 3767 |
|
|
2014
Q1 | $24K | Buy |
2,673
+1,460
| +120% | +$8.65K | ﹤0.01% | 4789 |
|
|
2013
Q4 | $5K | Buy |
+1,213
| New | +$5.67K | ﹤0.01% | 5042 |
|
Deutsche Bank's BSTG Position: Q4 2017 in Review
Deutsche Bank sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 7 shares.
Deutsche Bank first reported a position in BSTG in Q4 2013 and held it in 14 quarters. The position peaked at $341K in Q2 2014. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.
- Deutsche Bank reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
- Deutsche Bank sold 7 Biostage, Inc. Common Stock shares in Q4 2017.
- Deutsche Bank first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 14 quarters.
- Deutsche Bank's Biostage, Inc. Common Stock position peaked at $341K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.
Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.